NTx’s new services offering provides faster and more affordable high-integrity, complex mRNA production powered by NTxscribe® ...

ExPLoRNA Therapeutics specialises in mRNA innovations, focusing on new cap analogues that are crucial for successful protein ...

LineaRx will present its Linea™ IVT platform - a combination of an enzymatically produced DNA template (Linea™ DNA IVT template) coupled with a next-generation RNA polymerase (Linea™ RNAP) - as a ...

Primrose Bio, a leading biotechnology company specializing in technologies that improve the manufacturing of next-generation ...

Milestone marks a significant step toward producing mRNA vaccines in Canada by 2025 CAMBRIDGE, MA / ACCESSWIRE / September 9, 2024 / Moderna, Inc. (Nasdaq:MRNA) today announced that its ...

NTx Services offers faster turnaround, more flexibility, and scalability than traditional mRNA production processes by leveraging the NTxscribe continuous flow in vitro transcription (IVT ...